Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

38.36
Delayed Data
As of Sep 04
 +0.36 / +0.95%
Today’s Change
30.30
Today|||52-Week Range
39.95
+12.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues168.8M184.4M180.0M189.9M
 
 
 
 
 
Cost of Goods Sold32.0M31.8M29.9M30.9M
 
 
 
 
 
Depreciation And Amortization6.0M6.0M6.4M6.6M
 
 
 
 
 
 
Operating ExpensesGross Income130.9M146.5M143.7M152.4M
 
 
 
 
 
General Expenses105.0M110.2M108.0M116.2M
 
 
 
 
 
Research And Development22.6M17.5M16.7M18.7M
 
 
 
 
 
Total Operating Expenses142.9M148.1M144.2M153.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income25.9M36.3M35.7M36.2M
 
 
 
 
 
Other Expenses-98.0K1.5M-298.0K-800.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income25.9M37.9M35.6M35.5M
 
 
 
 
 
Income Taxes-9.9M-13.9M-14.1M-16.8M
 
 
 
 
 
Net Income16.0M24.0M21.5M18.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS72.8M72.5M70.7M69.4M
 
 
 
 
 
Shares To Calculate EPS Diluted76.1M75.4M73.9M72.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.21$0.32$0.29$0.26
 
 
 
 
 
EPS Diluted$0.21$0.32$0.29$0.26